Understanding BRCA1's Role in Breast and Ovarian Cancer
BRCA1 and the regulation of chromatin dynamics in gene expression
This research explores how the BRCA1 gene, known for its link to breast and ovarian cancer, works to keep our cells healthy and prevent disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-11086792 on NIH RePORTER |
What this research studies
The BRCA1 gene is a crucial protector against breast and ovarian cancer, often called a 'master regulator' because it helps maintain the health of our genetic material. When BRCA1 doesn't work correctly, it can lead to problems with how cells manage stress, repair DNA, and control their growth, all of which are important in cancer development. This project uses a special cell-free system to closely watch how BRCA1 influences these vital cell processes. By understanding these basic mechanisms, we hope to uncover new ways to fight cancer.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to benefit individuals at risk for or diagnosed with hereditary breast and ovarian cancer associated with BRCA1 mutations.
Not a fit: Patients seeking immediate new treatments or direct clinical intervention would not find direct benefit from this basic science research.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of how BRCA1 prevents cancer, potentially opening doors for new strategies to treat or prevent breast and ovarian cancers linked to this gene.
How similar studies have performed: While the overall role of BRCA1 is well-established, this project uses a newly developed cell-free system to explore its specific mechanisms, offering a novel approach to understanding chromatin dynamics.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Long, David Thomas — Medical University of South Carolina
- Study coordinator: Long, David Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.